
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R2053353 | MC180295 | MC180295 ((rel)-MC180295) is a potent and selective CDK9-Cyclin T1 inhibitor, wi |
| R2053354 | GSK2983559 HCl | GSK2983559 free acid (compound 3) is a potent, specific and oral bioavailable re |
| R2053355 | PF04995274 | PF-04995274 is a potent, high-affinity, orally active and partial serotonin 4 re |
| R2053356 | BI671800;AP-761 | BI-671800 is a highly specific and potent antagonist of chemoattractant receptor |
| R2053357 | Nilotinib monohydrochloride monohydrate | Nilotinib monohydrochloride monohydrate is a second generation tyrosine kinase i |
| R2053358 | Bosutinib;SKI-606 | Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectivel |
| R2053359 | Radotinib Dihydrochloride | Radotinib(IY-5511) is a novel and selective BCR-ABL1 tyrosine kinase inhibitor w |
| R2053360 | Ribociclib succinate | Ribociclib succinate (LEE011 succinate) is a highly specific CDK4/6 inhibitor wi |
| R2053361 | Masitinib mesylate | Masitinib mesylate (AB-1010 mesylate) is a potent, orally bioavailable, and sele |
| R2053362 | S-Lorlatinib | Lorlatinib (PF-06463922) is a selective, orally active, brain-penetrant and ATP- |
| R2053363 | Fimasartan | Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used fo |
| R2053364 | Fimasartan Potassium Trihydrate;BR-A 657 | Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used fo |
| R2053365 | Efonidipine | Efonidipine(NZ-105) is a dual T-type and L-type calcium channel blocker (CCB). I |
| R2053366 | Efonidipine Hydrochloride | Efonidipine Hcl (NZ-105) is a dual T-type and L-type calcium channel blocker (CC |
| R2053367 | Efonidipine Hydrochloride ethanol (1:1:1) | Efonidipine hydrochloride monoethanolate (NZ-105 hydrochloride monoethanolate) i |
| R2053368 | Vonoprazan Fumarate | Vonoprazan Fumarate (TAK-438) is an orally active potassium-competitive acid blo |
| R2053369 | Vonoprazan;TAK438 | Vonoprazan (TAK-438 free base) is an orally active potassium-competitive acid bl |
| R2053370 | R-Avanafil | Avanafil(TA-1790) is a potent and highly selective phosphodiesterase-5(PDE-5) in |
| R2053371 | Ozanimod hydrochloride | Ozanimod (RPC-1063) is a potent and selective S1P1 and S1P5 receptor agonist wit |
| R2053372 | Revefenacin;TD4208 | Revefenacin (TD-4208; GSK1160724) is a potent mAChR antagonist; has a high affin |
| R2053373 | S-Ruxolitinib | Ruxolitinib S enantiomer is the S-enantiomer of Ruxolitinib. Ruxolitinib S enant |
| R2053374 | Cefcapene pivoxil hydrochloride | Cefcapene pivoxil hydrochloride hydrate is a prodrug and an orally active 3rd-ge |
| R2053375 | Peramivir trihydrate | Peramivir trihydrate (RWJ-270201 trihydrate;BCX-1812 trihydrate) is a highly pot |
| R2053376 | Mirabegron | Mirabegron is a selective β3-adrenoceptor agonist with EC50 of 22.4 nM. |
| R2053377 | Dolutegravir;GSK1349572 | Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integ |